Suchergebnisse - "Benelli, Matteo"

PubPharm (6)

1

BRCA2 Germline Mutations Identify Gastric Cancers Responsive to PARP Inhibitors

enthalten in: Cancer research | 2023

von Petrelli, A. | Rizzolio, S. | Pietrantonio, F. | +30

2

Activation of the IFN Signaling Pathway is Associated with Resistance to CDK4/6 Inhibitors and Immune Checkpoint Activation in ER-Positive Breast Cancer

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2021

von De Angelis, C. | Fu, X. | Cataldo, M. | +27

ErratumIn: Clin Cancer Res. 2021 Sep 1;27(17):4939. - PMID 34470810

3

Glucose Metabolic Reprogramming of ER Breast Cancer in Acquired Resistance to the CDK4/6 Inhibitor Palbociclib

enthalten in: Cells | 2020

von Lorito, N. | Bacci, M. | Smiriglia, A. | +11

4

Biomarker-guided implementation of the old drug temozolomide as a novel treatment option for patients with metastatic colorectal cancer

enthalten in: Cancer treatment reviews | 2020

von Pietrantonio, F. | Randon, G. | Romagnoli, D. | +3

5

Prognostic role of serum thymidine kinase 1 activity in patients with hormone receptor-positive metastatic breast cancer : Analysis of the randomised phase III Evaluation of Faslodex versus Exemestane Clinical Trial (EFECT)

enthalten in: European journal of cancer (Oxford, England : 1990) | 2019

von McCartney, A. | Biagioni, C. | Schiavon, G. | +16

6

Patient derived organoids to model rare prostate cancer phenotypes

enthalten in: Nature communications | 2018

von Puca, L. | Bareja, R. | Prandi, D. | +30

1
[1]